Physician profile
Robert Hilton Mcdonald
NPI 1992743066
$2,138.64
in general payments reported to CMS, 2019-2025
19 companies · $581 in 2025
The $581 reported for 2025 was more than what a typical Otolaryngic Allergy provider received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $646 · 2020: $192 · 2021: $290 · 2022: $149 · 2023: $247 · 2024: $34.15 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642 · Education: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.68 |
| Education | $220.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $570.29 | 2019-2025 | Nucala, Arexvy, Shingrix |
| Genzyme Corporation | $265.26 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $220.87 | 2019-2025 | Dupixent |
| Stryker Corporation | $220.08 | 2019-2025 | Hemopore |
| Intersect Ent, INC. | $200.84 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $157.90 | 2021-2025 | |
| Medtronic USA, INC. | $109.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $62.81 | 2019-2020 | |
| Alk-Abello, INC | $59.44 | 2020-2022 | |
| Tei Medical INC. | $43.04 | 2019 | |
| Integra Lifesciences Corporation | $41.01 | 2019 | |
| Acclarent, INC | $38.02 | 2019 | |
| Kaleo, INC. | $28.38 | 2019-2022 | |
| Shire North American Group INC | $28.05 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $27.49 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $18.41 | 2023 | Inspire |
| Medtronic, INC. | $18.38 | 2024 | Pteye Parathyroid Detection System |
| Phadia US INC. | $17.39 | 2021 | |
| Genentech USA, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.